Clinical Trial Update: The Acute Cardiovascular Effects of Nicotine in E-cigarettes (ACE) Study [Phase 1]

View source ↗

Summary

The ACE study evaluating the acute cardiovascular effects of nicotine in electronic cigarettes (Phase 1) has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease

Drugs mentioned

• Nicotine (nicotine)

Snippet

Sponsor: University of Louisville | Conditions: Cigarette Smoking Toxicity, Nicotine | Phase 1 | Status: WITHDRAWN